Google’s pitch to regulate AI

Presented by PhRMA: Delivered daily by 10 a.m., Pulse examines the latest news in health care politics and policy.
Dec 05, 2023 View in browser
 
POLITICO's Pulse newsletter logo

By Chelsea Cirruzzo and Ben Leonard

Presented by

PhRMA

With Evan Peng

Driving The Day

Google headquarters.

Google is vying to dominate in AI and sees opportunity in the health care industry. | Justin Sullivan/Getty Images

LOUD-AND-CLEAR MESSAGE — Regulations to govern artificial intelligence in health care are in the works, and Google says it’s here to help.

That’s the message lobbyists for the tech giant — whose motto is “do the right thing” — are sending, but policymakers have barely begun considering what the rules should be.

In the meantime, legal experts, legislators and small startups worry about the search firm’s record on privacy and its ability to capture the regulators, POLITICO’s Ruth Reader reports.

Google’s pitch: It’s vying to dominate in AI and sees opportunity in the health care industry. The company’s tech scours medical records, research papers, imaging and clinical guidelines to help doctors diagnose diseases and evaluate treatment options.

Hospitals already use AI even though the government hasn’t yet written rules ensuring its safety and effectiveness.

President Joe Biden issued an executive order in late October asking his agencies to devise a plan.

In mid-November, Google published a policy agenda for AI, calling for pro-innovation laws and infrastructure to support the advancement and adoption of AI.

It’s hired former Food and Drug Administration officials to guide its talks with the Biden administration since the FDA is leading the rulemaking.

And FDA Commissioner Robert Califf used to work for Google’s parent company.

Even so: Over the summer, Sen. Mark Warner (D-Va.) sent a letter to Google CEO Sundar Pichai, saying he was troubled that hospitals use the company’s AI without sufficient vetting.

“There is great promise in many of these tools to save more lives,” he told POLITICO, adding that “they also have the potential to do exactly the opposite — harm patients and their data, reinforce human bias and add burdens to providers as they navigate a clinical and legal landscape without clear norms.”

And small rivals see a move to dominate health care AI in the same way Google dominates internet search.

“They’re going to basically create a setup where we will be dependent just on them to move forward,” said Punit Soni, CEO of clinical note-taking company Suki AI, referring to big tech players in health care, including Google.

WELCOME TO TUESDAY PULSE. The House Energy and Commerce Committee today will mark up 44 pieces of legislation, including bills on telehealth in Medicare, PBMs and biosimilars. Any bills you’re watching? Let us know by emailing ccirruzzo@politico.com and bleonard@politico.com and follow along @ChelseaCirruzz o and @_BenLeonard_.

TODAY ON OUR PULSE CHECK PODCAST, your host Ben talks with POLITICO health care reporter Alice Miranda Ollstein, who explains why calls by former President Donald Trump to replace the popular Affordable Care Act, which insures more than 40 million people, could fall on deaf ears.

Play audio

Listen to today's Pulse Check podcast

 

A message from PhRMA:

Middlemen like PBMs are charging fees tied to the price of medicines, which means they make more money when the price of a medicine goes up. This business model allows PBM profits to soar and can lead to higher costs for patients. It’s time to lower costs by holding middlemen accountable.

 
In Congress

A nurse treats patient's injuries from xylazine in an outreach van

The Tranq Research Bill aims to keep first responders safe from deadly combinations of xylazine. | Matt Rourke/AP Photo

TRANQ RESEARCH ACT TO BIDEN — The House endorsed by voice vote Monday a Senate-amended legislation requiring the National Institute of Standards and Technology to coordinate science and research into illegal drugs containing the horse tranquilizer xylazine, which has increasingly been mixed with illicit fentanyl to deadly effect, POLITICO’s Carmen Paun reports.

The bill, named the Tranq Research Act, now heads to President Joe Biden for his signature.

The bill authorizes critical research and development to help authorities better understand, detect and handle combinations of xylazine, also known as Tranq, and other drugs, said Rep. Frank Lucas (R-Okla.), chair of the House Science, Space and Technology Committee, during the floor debate Monday.

The NIST will help develop technologies to quickly identify and safely handle drugs containing Tranq, which will keep first responders safe, said bill sponsors Mike Collins (R-Ga.), chair of the Science Research and Technology Subcommittee, and Zoe Lofgren (D-Calif.), the top Democrat in the Science, Space and Technology Committee.

 

GET A BACKSTAGE PASS TO COP28 WITH GLOBAL PLAYBOOK: Get insider access to the conference that sets the tone of the global climate agenda with POLITICO's Global Playbook newsletter. Authored by Suzanne Lynch, Global Playbook delivers exclusive, daily insights and comprehensive coverage that will keep you informed about the most crucial climate summit of the year. Dive deep into the critical discussions and developments at COP28 from Nov. 30 to Dec. 12. SUBSCRIBE NOW.

 
 
At the Agencies

In this Wednesday, Jan. 15, 2020 file photo, students discard food at the end of their lunch period as part of a lunch waste composting program at an elementary school in Connecticut.

The Biden administration has put forth suggestions for how to reduce food waste. | Dave Zajac/Record-Journal via AP

WASTE NOT, WANT NOT— Every American, on average, wastes nearly 350 pounds of food a year, and a lot of it is perfectly good, Evan reports.

As a result, the Biden administration has proposed steps to tackle food waste. The strategy tasks the FDA, the USDA and the EPA with educating the public about food-packaging labels since designations like “best before” or “expiration date” prompt people to throw away food that’s often still safe to eat.

The labels aren’t federally regulated and mean different things on different products.

The strategy also has the FDA working with the food industry to handle product recalls more carefully so food isn’t trashed unnecessarily.

And it asks the agency to provide more support for organizations that donate food.

Why it matters: In 2015, the Obama administration announced a goal to cut food loss and waste in half by 2030.

Meeting that goal remains far off. In 2016, the EPA found a baseline of 328 pounds of food wasted per person in the retail, food service and residential sectors. In 2019, the latest data available, that count increased to 349 pounds per person.

The White House announced the strategy at the U.N. climate conference in Dubai, underscoring the potential for food-waste reduction efforts to decrease the greenhouse gas emissions that public health officials increasingly see as a danger to well-being.

What’s next? The draft strategy is open for public comment, which closes on Jan. 4.

 

A message from PhRMA:

Advertisement Image

 
Providers

SURVEY SAYS — Many people of color prepare for their health care appointments expecting insults from providers or staff, according to a survey out today by KFF.

Why it matters: Experiences with racism — which many respondents also reported in their daily life — are associated with worse health outcomes, researchers said.

The large, nationally representative survey sheds light on people's negative experiences at the doctor’s office, such as encountering providers who assume something about them, refuse to prescribe a pain medication or ignore their direct requests or questions. About a quarter of Black adults and 1 in 5 American Indian and Alaska Native adults said the experiences were due to their race and ethnicity.

 Other results: Sixty percent of Black adults, about half of American Indian and Alaska Native adults and Hispanic adults, and 42 percent of Asian adults said they feel they must be careful about their appearance to be treated fairly at their appointments. One-third of white adults reported the same.

People who experienced discrimination in their daily lives at least a few times a year were twice as likely as those who didn’t say they felt anxious, lonely or depressed, according to the study.

MORE NURSES ON STRIKE Nurses at three hospitals in Texas and Kansas will strike Wednesday to protest what they say are unsafe working conditions.

The one-day strike, announced for nurses at three Ascension health care facilities by National Nurses United, follows similar strikes by health care workers, including one at the Robert Wood Johnson University Hospital in October that drew the attention of the Senate health committee. Sen. Bernie Sanders (I-Vt.), who chairs the committee, teamed up with Kansas Republican Sen. Roger Marshall on a bill to reorganize primary care, including investing in the nursing workforce.

An Ascension spokesperson told Pulse in a statement that it was disappointed in National Nurses United for opting to strike, “once again creating unnecessary uncertainty for our associates and their families, and concern for our patients and their loved ones.” The company says it has a contingency plan and will continue to bargain with the union.

Many recent strikes by health care workers, including the one planned for Wednesday, have centered around understaffing, with providers saying a lack of available staff contributes to unsafe working conditions and burnout.

Two thousand nurses at Ascension facilities in Wichita, Kansas, and Austin, Texas, held a strike in June.

 

JOIN WOMEN RULE ON 12/12: For centuries, women were left out of the rooms that shaped policy, built companies and led countries. Now, society needs the creativity and entrepreneurship of women more than ever. How can we make sure that women are given the space and opportunity to shape the world’s future for the better? Join POLITICO's Women Rule on Dec. 12 for Leading with Purpose: How Women Are Reinventing the World to explore this and more. REGISTER HERE.

 
 
Names in the News

Rosemary Weldon has joined accountable care organization Aledade as chief product officer. She previously was VP of digital health product management at CVS Health.

WHAT WE'RE READING

Chelsea reports on the split in the Supreme Court on the Purdue Pharma settlement.

STAT reports on how sickle cell disease was the first disease treated by CRISPR.

NPR reports on how the nonprofit behind Sesame Street is using the muppets to educate young children on the opioid crisis.

 

A message from PhRMA:

Middlemen like PBMs are charging fees tied to the price of medicines, which means they make more money when the price of a medicine goes up. This business model allows PBM profits to soar and can lead to higher costs for patients. It’s time to lower costs by holding middlemen accountable.

 
 

Follow us on Twitter

Dan Goldberg @dancgoldberg

Chelsea Cirruzzo @chelseacirruzzo

Katherine Ellen Foley @katherineefoley

Lauren Gardner @Gardner_LM

Kelly Hooper @kelhoops

Robert King @rking_19

Ben Leonard @_BenLeonard_

David Lim @davidalim

Megan Messerly @meganmesserly

Alice Miranda Ollstein @aliceollstein

Carmen Paun @carmenpaun

Daniel Payne @_daniel_payne

Evan Peng @thepngfile

Ruth Reader @RuthReader

Erin Schumaker @erinlschumaker

Megan R. Wilson @misswilson

 

Follow us

Follow us on Facebook Follow us on Twitter Follow us on Instagram Listen on Apple Podcast
 

To change your alert settings, please log in at https://www.politico.com/_login?base=https%3A%2F%2Fwww.politico.com/settings

This email was sent to salenamartine360.news1@blogger.com by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA

Unsubscribe | Privacy Policy | Terms of Service

Post a Comment

Previous Post Next Post